Tyler Reinsch

Statistics

Publications

Citations

110

H-Index

Active since

2018

Affiliations

University of North Carolina at Chapel Hill(Current)

Research Triangle Park Foundation

Optum (United States)

GlaxoSmithKline (United States)

Tyler Reinsch is an author at University of North Carolina at Chapel Hill specializing in pulmonology, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease pharmacotherapy.

Publications per year

2018–2020

Publications

Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma

Richard H. Stanford, Carlyne M. Averell, Emily D. Parker et al. · The Journal of Allergy and Clinical Immunology In Practice · 2019 · 32 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting

Michael Bogart, Mrudula B. Glassberg, Tyler Reinsch et al. · Respiratory Medicine · 2018 · 28 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study

Michael Bogart, Richard H. Stanford, Tyler Reinsch et al. · Respiratory Medicine · 2018 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Assessment of COPD-related outcomes in patients initiating a once daily or twice daily ICS/LABA

Richard H. Stanford, Emily D. Parker, Tyler Reinsch et al. · Respiratory Medicine · 2019 · 16 citations

Medicine, Clinical Sciences, Internal Medicine +13

Validation and Assessment of the COPD Treatment Ratio as a Predictor of Severe Exacerbations

Richard H. Stanford, Stephanie Korrer, Lee Brekke et al. · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2020 · 12 citations · Full text

Medicine, Clinical Pharmacy, Clinical Epidemiology +14

1–5 of 5